Most People With Long COVID Do Not Recover in Second Year of Illness
By Lori Solomon HealthDay Reporter
THURSDAY, Jan. 23, 2025 -- The majority of working-age patients with postacute sequelae of COVID-19/post-COVID-19 syndrome (PCS) do not recover in the second year of their illness, according to a study published online Jan. 23 in PLOS Medicine.
Raphael S. Peter, from Ulm University in Germany, and colleagues examined clinical characteristics and diagnostic findings among patients with PCS persisting for more than one year and assessed risk factors for PCS persistence versus improvement. The analysis included data from 982 participants (aged 18 to 65 years) with PCS and 576 matched individuals without PCS at six to 12 months after acute infection (phase 1) and at another 8.5 months (phase 2).
The researchers found that at phase 2, 67.6 percent of the patients with PCS at phase 1 developed persistent PCS, while 78.5 percent of the recovered participants remained free of health problems related to PCS. Improvement was associated with mild acute index infection, previous full-time employment, educational status, no specialist consultation, and not attending a rehabilitation program, while development of new PCS symptoms among those initially recovered was associated with an intercurrent secondary severe acute respiratory syndrome coronavirus 2 infection and educational status. Patients with persistent PCS were less frequently never smokers (61.2 versus 75.7 percent), were more often obese (30.2 versus 12.4 percent), and had lower educational status (university entrance qualification, 38.7 versus 61.5 percent). The predominant symptom clusters persisted (fatigue/exhaustion, neurocognitive disturbance, chest symptoms/breathlessness, and anxiety/depression/sleep problems). Exercise intolerance with postexertional malaise for >14 hours (35.6 percent) and symptoms of myalgic encephalomyelitis/chronic fatigue syndrome (11.6 percent) were seen with persistent PCS.
"In the majority of patients, PCS symptoms did not improve in the second year of their illness and typically continued to include fatigue and measurable exercise intolerance and cognition deficits, but there seems to be no major pathology in laboratory investigations," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2025-01-25 00:00
Read more
- Late Eating Tied to Poor Glucose Tolerance
- One in Four Older U.S. Veterans Report Cardiovascular Disease Diagnosis
- More Activity, Less Risk: Tell Your MD How Much You Move
- Recommendations Provided for Treating, Preventing HIV
- Alcohol Intake Increases Cancer Risk, Beverages Should Carry Warning: Surgeon General
- Link Between Gum Disease, Brain Function Exists, Small Study Says
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions